4
Changes in Ownership
Kiniksa Pharmaceuticals International, plc Filed Acc 0001415889-24-010505
CHIEF ACCOUNTING OFFICER gave up 1,666 shares (to pay taxes)
- CHIEF ACCOUNTING OFFICER acquired 3,932 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Megna Michael R CHIEF ACCOUNTING OFFICER | 2024-04-08 | Option exercise | +3,932 | 22,994 | D | ||
| Megna Michael R CHIEF ACCOUNTING OFFICER | 2024-04-08 | Shares withheld for taxes | −1,666 | $17.90 | $29,821 | 21,328 | D |
| Derivatives | |||||||
| Megna Michael R CHIEF ACCOUNTING OFFICER | 2024-04-04 | Grant or award · Share Option | +18,900 | 18,900 | D | ||
| Megna Michael R CHIEF ACCOUNTING OFFICER | 2024-04-04 | Grant or award · Restricted Share Unit | +9,450 | 17,122 | D | ||
| Megna Michael R CHIEF ACCOUNTING OFFICER | 2024-04-08 | Option exercise · Restricted Share Unit | −3,932 | 13,190 | D | ||
Loading xslF345X05/form4-04082024_090419.xml…